Publications, Pharmaceutical

Developing a Dry Powder Formulation for Aptar Pharma Prohaler®

Aptar Pharma Prohaler® is a novel, high performance, multidose dry powder inhaler device with a patient-centric design developed to promote patient compliance.

This paper describes the optimization of a model formulation for Prohaler® via manipulation of the concentration of fine lactose and the inclusion of a force control agent, to reduce the strength of interparticle forces and promote dose deaggregation. The relationship between formulation composition and dissolution profile was also investigated. The inclusion of a force control agent was shown to be highly beneficial in promoting aerosolization, resulting in a higher fine particle mass and a finer mass median aerodynamic diameter. This effect was robust with respect to lactose fine concentration which in the absence of a force control agent was also observed to correlate positively with fine particle mass. Consideration of the use of force control agents is highly recommended when developing formulations for Prohaler®.

Download Publication
8 May 2021

Learn more about Prohaler®

Find Out More

This Might Also Be of Interest

29 May 2025

Overcoming Challenges in Preclinical Studies for Intranasal and Inhalation Programs

Webinars, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Market Insights, Product Solutions

Read More
21 May 2025

Low GWP pMDI Q&A with Aptar’s ZEN30 Futurity™ Valve Solution

Publications, Pharmaceutical, Market Insights, Product Solutions, Sustainability, Drug Delivery Innovations, Brand Differentiation

Read More
19 May 2025

Innovations in Pulmonary Care: DPI and NPLI Lead the Way

Publications, Pharmaceutical, Innovation & Insights, Drug Delivery Innovations, Market Insights, Product Solutions

Read More
23 Apr 2025

Spotlight on Emissions Reductions for A Lower CO2 Footprint in Pharmaceutical Packagi...

Publications, Pharmaceutical, Sustainability, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3 20

Request Access

Close

Requesting access to Developing a Dry Powder Formulation for Aptar Pharma Prohaler®.

  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is hidden when viewing the form
  • This field is for validation purposes and should be left unchanged.
Back To Top